27 results match your criteria: "Portuguese Institute of Oncology--Porto[Affiliation]"

TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.

Cancer Genet Cytogenet

June 2005

Molecular Oncology Unit, Portuguese Institute of Oncology-Porto, Laboratórios 4 Piso, Rua Dr. António Bernardino Almeida, 4200-072 Porto, Portugal.

High-risk human papillomavirus are essential for the development of cervical cancer; however, TP53 is the most frequently altered tumor suppressor gene among tumors and is described as a cofactor for cervical carcinogenesis. TP53 has two common polymorphic forms encoding either proline or arginine, at position 72, and the presence of homozygous arginine has been reported as a risk factor for cervical cancer in many populations. We evaluated the effect of this TP53 polymorphism in a northern Portuguese population.

View Article and Find Full Text PDF

Altered Cyclin D1 activity, due to gene amplification and/or protein overexpression, is related to the development of several human cancers, including head and neck SCC. This study investigated the relationship between CCND1 A870G gene polymorphism and amplification with the development and progression of laryngeal SCC, considering the implications of tumor localization and tobacco exposure. The study population consisted of 66 larynx cancer patients and 110 healthy individuals.

View Article and Find Full Text PDF